Tonix Pharma(TNXP)
$3.01-0.23 (-7.10%)
TNXP
Tonix Pharma financials statements
$3.01
At close:-0.23 (-7.10%)
Want to see TNXP full AI Analyst Report?
Tonix Pharma (TNXP) Ratios
5,135 Followers
Tonix Pharma Ratios
TNXP's free cash flow for Q3 2026 was $-41.68M. For the 2026 fiscal year, TNXP's free cash flow was decreased by $-603.00K and operating cash flow was $-41.07M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.42 | 6.50 | 2.53 | 7.19 | 8.71 |
| Quick Ratio | 7.23 | 6.04 | 1.78 | 7.19 | 8.71 |
| Cash Ratio | 6.73 | 5.40 | 1.32 | 6.61 | 8.23 |
| Solvency Ratio | -3.81 | -5.43 | -2.30 | -5.89 | -4.16 |
| Operating Cash Flow Ratio | -3.24 | -3.33 | -5.40 | -5.39 | -3.48 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -43.41 | 0.00 | 0.00 |
| Net Current Asset Value | $ 196.85M | $ 95.67M | $ -1.16M | $ 112.27M | $ 166.87M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.03 | 0.06 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.04 | 0.09 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.04 | 0.09 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.03 | 0.06 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.13 | 1.17 | 1.46 | 1.09 | 1.10 |
| Debt Service Coverage Ratio | -1370.87 | 0.00 | -48.55 | 0.00 | 0.00 |
| Interest Coverage Ratio | -1412.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.16 | 2.34 | 5.36 | 0.25 | 1698.54 |
| Net Debt to EBITDA | 1.69 | 1.26 | 0.13 | 1.08 | 1.93 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.65% | 23.07% | 38.97% | 0.00% | 0.00% |
| EBIT Margin | -945.54% | -770.20% | -1523.94% | 0.00% | 0.00% |
| EBITDA Margin | -930.85% | -736.31% | -1468.70% | 0.00% | 0.00% |
| Operating Profit Margin | -959.05% | -1354.28% | -1523.94% | 0.00% | 0.00% |
| Pretax Profit Margin | -946.22% | -1288.25% | -1501.78% | 0.00% | 0.00% |
| Net Profit Margin | -946.22% | -1288.25% | -1501.78% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -946.22% | -1288.25% | -1501.78% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.66% | 95.12% | 98.55% | 98.33% | 99.97% |
| Return on Assets (ROA) | -44.75% | -79.83% | -75.53% | -48.84% | -38.31% |
| Return on Equity (ROE) | -50.59% | -93.18% | -110.55% | -53.20% | -42.19% |
| Return on Capital Employed (ROCE) | -51.03% | -94.55% | -87.32% | -54.02% | -42.12% |
| Return on Invested Capital (ROIC) | -51.00% | -94.37% | -85.66% | -53.90% | -42.02% |
| Return on Tangible Assets | -44.76% | -79.89% | -81.15% | -48.86% | -38.33% |
| Earnings Yield | -93.29% | -174.19% | -4.94% | -0.46% | -71.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.34 | 1.28 | 1.69 | 0.00 | 0.00 |
| Payables Turnover | 1.06 | 1.71 | 1.25 | 0.00 | 0.00 |
| Inventory Turnover | 1.42 | 0.92 | 0.34 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.28 | 0.24 | 0.08 | 0.00 | 0.00 |
| Asset Turnover | 0.05 | 0.06 | 0.05 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.09 | 0.16 | 0.11 | 0.00 | 0.00 |
| Cash Conversion Cycle | 182.15 | 467.35 | 1013.65 | 0.00 | 0.00 |
| Days of Sales Outstanding | 271.68 | 285.81 | 215.67 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 256.25 | 395.22 | 1089.15 | 0.00 | 0.00 |
| Days of Payables Outstanding | 345.78 | 213.69 | 291.17 | 0.00 | 0.00 |
| Operating Cycle | 527.93 | 681.03 | 1304.82 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -11.73 | -26.92 | -55.69 | -31.95 | -134243.26 |
| Free Cash Flow Per Share | -12.13 | -26.97 | -60.00 | -47.64 | -196973.74 |
| Dividend Paid and CapEx Coverage Ratio | -29.64 | -507.71 | -12.92 | -2.04 | -2.14 |
| Capital Expenditure Coverage Ratio | -29.64 | -507.71 | -12.92 | -2.04 | -2.14 |
| Operating Cash Flow Coverage Ratio | -76.28 | -11.50 | -10.39 | -129.02 | -79.03 |
| Operating Cash Flow to Sales Ratio | -7.62 | -6.04 | -13.13 | 0.00 | 0.00 |
| Free Cash Flow Yield | -77.63% | -81.77% | -4.65% | -0.61% | -86.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.07 | -0.19 | -20.25 | -217.08 | -1.40 |
| Price-to-Sales (P/S) Ratio | 10.14 | 7.40 | 304.09 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.54 | 0.53 | 22.38 | 115.48 | 0.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.29 | -1.22 | -21.49 | -163.65 | -1.16 |
| Price-to-Operating Cash Flow Ratio | -1.33 | -1.23 | -23.16 | -244.01 | -1.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.00 | -0.03 | 2.18 | -0.00 |
| Enterprise Value Multiple | 0.60 | 0.25 | -20.57 | -214.78 | 0.53 |
| Enterprise Value | -73.38M | -18.83M | 2.35B | 23.81B | -48.85M |
| EV to EBITDA | 0.60 | 0.25 | -20.57 | -214.78 | 0.53 |
| EV to Sales | -5.60 | -1.87 | 302.14 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.71 | 0.31 | -21.36 | -162.83 | 0.44 |
| EV to Operating Cash Flow | 0.73 | 0.31 | -23.01 | -242.79 | 0.65 |
| Tangible Book Value Per Share | 28.79 | 61.60 | 51.76 | 67.47 | 388384.59 |
| Shareholders’ Equity Per Share | 28.80 | 61.66 | 57.61 | 67.51 | 388597.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.54 | 4.46 | 4.24 | 0.00 | 0.00 |
| Net Income Per Share | -14.57 | -57.45 | -63.69 | -35.91 | -163967.71 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.67 | 0.99 | 0.98 | 1.00 |
| Research & Development to Revenue | 3.39 | 4.01 | 11.16 | 0.00 | 0.00 |
| SG&A to Revenue | 6.54 | 3.97 | 4.47 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.46 | 0.47 | 1.19 | 0.00 | 0.00 |
| Income Quality | 0.81 | 0.47 | 0.87 | 0.89 | 0.82 |
Currency in USD

